I think there are some good takeouts including the risks ahead.
I liked Frazis capital report , highlighting why big pharma likes taking good companies out at phase 2 therapy. If results do stay as positive as they have been, phase 2 theronostic are due mid year for Clarity. It's going to be a hell of a ride in the months ahead.
I think there are some good takeouts including the risks ahead....
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$5.19 |
Change
0.005(0.10%) |
Mkt cap ! $1.619B | |||
| Open | High | Low | Value | Volume |
| $5.26 | $5.28 | $5.11 | $1.377M | 265.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 3517 | $5.18 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.19 | 2510 | 3 |
View Market Depth
| Last trade - 11.17am 07/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$5.22 |
Change
0.005 ( 0.78 %) |
||||
| Open | High | Low | Volume | ||
| $5.22 | $5.24 | $5.11 | 244347 | ||
| Last updated 11.36am 07/06/2024 ? | |||||
| CU6 (ASX) Chart |